Statistical Challenges in the Conduct and Management of Ongoing Clinical Trials During the COVID-19 Pandemic-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Statistical Challenges in the Conduct and Management of Ongoing Clinical Trials During the COVID-19 Pandemic

Published:2020-10-01 Issue:4 Volume:12 Page:397-398
ISSN:1946-6315
Container-title:Statistics in Biopharmaceutical Research
language:en
Short-container-title:Statistics in Biopharmaceutical Research

Author:

Hamasaki Toshimitsu¹,Bretz Frank²³,Cooner Freda⁴,LaVange Lisa M.⁵,Posch Martin³^ORCID

Affiliation:

1. The George Washington University Biostatistics Center, Rockville, MD;

2. Clinical Development & Analytics, Novartis Pharma, Basel, Switzerland;

3. Section for Medical Statistics, Medical University of Vienna, Vienna, Austria;

4. Statistical Innovation, Amgen, Thousand Oaks, CA;

5. Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/19466315.2020.1828692

Reference15 articles.

1. Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials

2. Comment on “Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic”

3. Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience

4. Operational Experiences in China and Statistical Issues on the Conduct of Clinical Trials During the COVID-19 Pandemic

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and solutions in clinical research during the COVID‐19 pandemic: A narrative review;Health Science Reports;2023-08

2. Antiepileptogenesis after stroke—trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate;Epilepsia Open;2023-06-12

3. Estimators for handling COVID ‐19‐related intercurrent events with a hypothetical strategy;Pharmaceutical Statistics;2022-06-28

4. Editor’s Note;Statistics in Biopharmaceutical Research;2022-04-03

5. Statistical Issues and Challenges in Clinical Trials for COVID-19 Treatments, Vaccines, Medical Devices and Diagnostics;Statistics in Biopharmaceutical Research;2021-12-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3